Jefferies Maintains 'Hold' Rating on Myriad Genetics (MYGN) Post Q1, Estimates Lowered

Go back to Jefferies Maintains 'Hold' Rating on Myriad Genetics (MYGN) Post Q1, Estimates Lowered
Myriad Genetics, Inc. (NASDAQ: MYGN) Delayed: 4.52 -0.02 (0.44%)
Previous Close $4.54    52 Week High $45.34 
Open $4.54    52 Week Low $15.92 
Day High $4.62    P/E 1.94 
Day Low $4.42    EPS $2.33 
Volume 311,799